Patients Are Left With Few Options as GLP-1 Copycats Disappear

Footter provider Henry Meds does not offer insecurity of tirzepatide, but allowed patients to place the bulk orders before the stage. He went ahead and ordered a few months of valuable vials, but he does not know what to do when running. “I’m extremely frustrated because of what will happen,” he says. “Every drop of each roof is a little longer than each vial that I’m eking.” (As a publication, Henry Meds offers the ability to new and current patients 30-week semaglutide injections. Henry Meds did not respond to a request for comment.)

41-year-old Jim Bertel living in Colorado, Tirzepatide’s Tirzepatide to change his life, before he stopped his sale, he was able to collect the complex GLP-1 medicine. While working at the end of this month, it is not sure what to do, and he is holding Reddit and Facebook forums to find that telegraphic companies still present the drugs of drugs. “Currently, my plan is to get him a month bear.” “The provider is throppan into the provider.”

Jessie, who wants to identify only in the name, failed to access consecutive access through insurance or primary service provider, applied to a medical spa to get complex medications. Its provider first wrote a recipe for Wegovy, but says it is filled. Was able to add with a complex version when the med spa is available. However, at the end of last year, Jessie received a letter from the insurance company, saying that he would not cover Wegovy. Then he stopped writing recipes to write recipes for weight loss medications, said they were very hassle. The med returned to the SPA and recently became recently complicated semaglutitide, but said that the enterprise could not guarantee the progress of supply. He often travels to San Diego for work, because it is already thinking about taking drugs from Mexico. “The same meds, do not need a recipe and are cheaper,” he says. In Mexico, the brand name Wegovy can be purchased for about $ 200 per month.

Spoty Insurance coverage helped the driver’s request to QLP-1 products. Despite the approval of 30 or more body mass index, for patients with 30 or more, some insurance plans include an additional BMI or additional criterion if some insurance plans are a higher BMI or additional obesity. “Here’s, this is a disease as a disease as a disease like a disease,” Florencia Halperin, “will not be an employer who said,” We do not cover “,” Florencia Halperin. “

Amanda Bonello, the founder and CEO of the GLP-1 staff, not surprised to go to patients who helped the patients involved in these drugs. Bonello, GLP-1 products in itself, the effects of these drugs are not just about itself.